CDKL5 and ARX Mutations in Males With Early-Onset Epilepsy

详细信息    查看全文

• 作者：Ghayda M. Mirzaa ; MD^a ; ^{gmirzaa@uw.edu} ; Alex R. Paciorkowski ; MD^b ; Eric D. Marsh ; MD^c ; ^d ; Elizabeth M. Berry-Kravis ; MD ; PhD^e ; Livija Medne ; MS^c ; Art Grix ; MD^f ; Elaine C. Wirrell ; MD^g ; Berkley R. Powell ; MD^h ; Katherine C. Nickels ; MD^g ; Barbara Burton ; MDⁱ ; Andrea Paras ; MSⁱ ; Katherine Kim ; MSⁱ ; Wendy Chung ; MD^j ; William B. Dobyns ; MD^a ; Soma Das ; PhD^k
• 刊名：Pediatric Neurology
• 出版年：2013
• 出版时间：May, 2013
• 年：2013
• 卷：48
• 期：5
• 页码：367-377
• 全文大小：741 K

文摘

Mutations in CDKL5 and ARX are known causes of early-onset epilepsy and severe developmental delay in males and females. Although numerous males with ARX mutations associated with various phenotypes have been reported in the literature, the majority of CDKL5 mutations have been identified in females with a phenotype characterized by early-onset epilepsy, severe global developmental delay, absent speech, and stereotypic hand movements. To date, only 10 males with CDKL5 mutations have been reported. Our retrospective study reports on the clinical, neuroimaging, and molecular findings of 18 males with early-onset epilepsy caused by either CDKL5 or ARX mutations. These 18 patients include eight new males with CDKL5 mutations and 10 with ARX mutations identified through sequence analysis of 266 and 346 males, respectively, at our molecular diagnostic laboratory. Our large dataset therefore expands on the number of reported males with CDKL5 mutations and highlights that aberrations of CDKL5 and ARX combined are an important consideration in the genetic forms of early-onset epilepsy in boys.